{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:53:43Z","timestamp":1761587623300,"version":"build-2065373602"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020749","name":"Hubei Key Laboratory of Wudang Local Chinese Medicine Research","doi-asserted-by":"publisher","award":["WDCM2022007"],"award-info":[{"award-number":["WDCM2022007"]}],"id":[{"id":"10.13039\/501100020749","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81400288","81573244"],"award-info":[{"award-number":["81400288","81573244"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2022CFB453"],"award-info":[{"award-number":["2022CFB453"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014361","name":"Hubei University of Medicine","doi-asserted-by":"publisher","award":["2018QDJZR04"],"award-info":[{"award-number":["2018QDJZR04"]}],"id":[{"id":"10.13039\/501100014361","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.intimp.2023.109955","type":"journal-article","created":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T11:45:28Z","timestamp":1677930328000},"page":"109955","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The role of myeloid-derived immunosuppressive cells in cardiovascular disease"],"prefix":"10.1016","volume":"117","author":[{"given":"Qingmei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aihua","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinwen","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Handong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jixin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunlei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9071-2436","authenticated-orcid":false,"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.intimp.2023.109955_b0005","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/s41577-018-0065-8","article-title":"Cardioimmunology: the immune system in cardiac homeostasis and disease","volume":"18","author":"Swirski","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2023.109955_b0010","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11897-017-0337-9","article-title":"Inflammation - Cause or Consequence of Heart Failure or Both?","volume":"14","author":"Van Linthout","year":"2017","journal-title":"Curr. Heart Fail. Rep."},{"issue":"10","key":"10.1016\/j.intimp.2023.109955_b0015","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2967\/jnumed.120.255539","article-title":"The Latest Advances in Imaging Crosstalk Between the Immune System and Fibrosis in Cardiovascular Disease","volume":"62","author":"Heo","year":"2021","journal-title":"J. Nucl. Med."},{"issue":"2","key":"10.1016\/j.intimp.2023.109955_b0020","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nri3800","article-title":"Role of innate and adaptive immune mechanisms in cardiac injury and repair","volume":"15","author":"Epelman","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109955_b0025","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/0891693042000196200","article-title":"Mast cells and innate cytokines are associated with susceptibility to autoimmune heart disease following Coxsackievirus B3 infection","volume":"37","author":"Fairweather","year":"2004","journal-title":"Autoimmunity"},{"issue":"4","key":"10.1016\/j.intimp.2023.109955_b0030","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.7150\/ijbs.68865","article-title":"Mannan-Binding Lectin Deficiency Limits Inflammation-induced Myeloid-Derived Suppressor Cells Expansion via Modulating Tumor Necrosis Factor Alpha-triggered Apoptosis","volume":"18","author":"Dong","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.intimp.2023.109955_b0035","article-title":"Polyamines from myeloid-derived suppressor cells promote Th17 polarization and disease progression","author":"Hu","year":"2022","journal-title":"Mol. Ther. : J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.intimp.2023.109955_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1016059","article-title":"The prognostic value and therapeutic targeting of myeloid-derived suppressor cells in hematological cancers","volume":"13","author":"Fan","year":"2022","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109955_b0045","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13045-020-0843-1","article-title":"Myeloid-derived suppressor cells-new and exciting players in lung cancer","volume":"13","author":"Yang","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109955_b0050","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10549-013-2618-7","article-title":"Myeloid-derived suppressor cells in breast cancer","volume":"140","author":"Markowitz","year":"2013","journal-title":"Breast Cancer Res. Treatment."},{"key":"10.1016\/j.intimp.2023.109955_b0055","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4316584","article-title":"Phenotypic and Functional Diversities of Myeloid-Derived Suppressor Cells in Autoimmune Diseases","author":"Ma","year":"2018","journal-title":"Mediators Inflamm."},{"issue":"5\u20136","key":"10.1016\/j.intimp.2023.109955_b0060","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1159\/000489830","article-title":"Myeloid-Derived Suppressor Cells in Infection: A NGeneral Overview","volume":"10","author":"Medina","year":"2018","journal-title":"J. Innate Immun."},{"issue":"2","key":"10.1016\/j.intimp.2023.109955_b0065","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.18632\/oncotarget.12278","article-title":"On the origin of myeloid-derived suppressor cells","volume":"8","author":"Millrud","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.intimp.2023.109955_b0070","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines4040036","article-title":"The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression","volume":"4","author":"Umansky","year":"2016","journal-title":"Vaccines."},{"issue":"7","key":"10.1016\/j.intimp.2023.109955_b0075","first-page":"806","article-title":"Stimulation of immune-suppressive bone marrow cells by colony-stimulating factors","volume":"18","author":"Young","year":"1990","journal-title":"Exp. Hematol."},{"issue":"9","key":"10.1016\/j.intimp.2023.109955_b0080","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1172\/JCI80005","article-title":"Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected","volume":"125","author":"Marvel","year":"2015","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.intimp.2023.109955_b0085","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109955_b0090","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2131084","article-title":"Targeting depletion of myeloid-derived suppressor cells potentiates PD-L1 blockade efficacy in gastric and colon cancers","volume":"11","author":"Tang","year":"2022","journal-title":"Oncoimmunology."},{"issue":"10","key":"10.1016\/j.intimp.2023.109955_b0095","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1172\/JCI68189","article-title":"Myeloid-derived suppressor cell development is regulated by a STAT\/IRF-8 axis","volume":"123","author":"Waight","year":"2013","journal-title":"J. Clin. Investig."},{"issue":"10","key":"10.1016\/j.intimp.2023.109955_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006647","article-title":"IRF-8 regulates expansion of myeloid-derived suppressor cells and Foxp3+ regulatory T cells and modulates Th2 immune responses to gastrointestinal nematode infection","volume":"13","author":"Valanparambil","year":"2017","journal-title":"PLoS Pathogens."},{"issue":"3","key":"10.1016\/j.intimp.2023.109955_b0105","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109955_b0110","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4049\/jimmunol.1701019","article-title":"Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment","volume":"200","author":"Ostrand-Rosenberg","year":"2018","journal-title":"J. Immunol. (Baltimore, Md: 1950)"},{"issue":"2","key":"10.1016\/j.intimp.2023.109955_b0115","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1004983","article-title":"Phenotype, development, and biological function of myeloid-derived suppressor cells","volume":"5","author":"Zhao","year":"2016","journal-title":"Oncoimmunology."},{"issue":"4","key":"10.1016\/j.intimp.2023.109955_b0120","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00262-019-02302-2","article-title":"Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates","volume":"68","author":"Cassetta","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"issue":"2","key":"10.1016\/j.intimp.2023.109955_b0125","doi-asserted-by":"crossref","DOI":"10.3390\/cells11020310","article-title":"Myeloid-Derived Suppressor Cells in Solid Tumors","volume":"11","author":"Ma","year":"2022","journal-title":"Cells."},{"issue":"8","key":"10.1016\/j.intimp.2023.109955_b0130","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00262-012-1294-5","article-title":"Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology","volume":"61","author":"Dumitru","year":"2012","journal-title":"Cancer Immunol., Immunother.: CII."},{"issue":"8","key":"10.1016\/j.intimp.2023.109955_b0135","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109955_b0140","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4049\/jimmunol.0903573","article-title":"CD49d Is a New Marker for Distinct Myeloid-Derived Suppressor Cell Subpopulations in Mice","volume":"185","author":"Haile","year":"2010","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109955_b0145","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2567.2012.03566.x","article-title":"S100A9 a new marker for monocytic human myeloid-derived suppressor cells","volume":"136","author":"Zhao","year":"2012","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.intimp.2023.109955_b0150","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaf8943","article-title":"Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients","volume":"1","author":"Condamine","year":"2016","journal-title":"Sci. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109955_b0155","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12943-022-01657-y","article-title":"Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy","volume":"21","author":"Wu","year":"2022","journal-title":"Mol. Cancer."},{"issue":"3","key":"10.1016\/j.intimp.2023.109955_b0160","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00262-005-0048-z","article-title":"Role of immature myeloid cells in mechanisms of immune evasion in cancer","volume":"55","author":"Kusmartsev","year":"2006","journal-title":"Cancer Immunol Immunother."},{"issue":"13","key":"10.1016\/j.intimp.2023.109955_b0165","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1158\/0008-5472.CAN-08-4625","article-title":"The liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppression","volume":"69","author":"Ilkovitch","year":"2009","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.intimp.2023.109955_b0170","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11060-015-1720-6","article-title":"Myeloid derived suppressor cell infiltration of murine and human gliomas is associated with reduction of tumor infiltrating lymphocytes","volume":"122","author":"Raychaudhuri","year":"2015","journal-title":"J Neurooncol."},{"key":"10.1016\/j.intimp.2023.109955_b0175","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.3389\/fimmu.2019.03070","article-title":"Deciphering the Crosstalk Between Myeloid-Derived Suppressor Cells and Regulatory T Cells in Pancreatic Ductal Adenocarcinoma","volume":"10","author":"Siret","year":"2019","journal-title":"Front Immunol."},{"issue":"13","key":"10.1016\/j.intimp.2023.109955_b0180","doi-asserted-by":"crossref","first-page":"6807","DOI":"10.1158\/0008-5472.CAN-05-3755","article-title":"CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1(+)CD11b(+) myeloid cells","volume":"66","author":"Yang","year":"2006","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.intimp.2023.109955_b0185","first-page":"295","article-title":"MHC gene control of the natural killer system at the level of the target and the host","volume":"2","author":"K\u00e4rre","year":"1991","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.intimp.2023.109955_b0190","first-page":"9","article-title":"Reactive Oxygen Species as Regulators of MDSC-Mediated Immune Suppression","author":"Ohl","year":"2018","journal-title":"Front. Immunol."},{"issue":"24","key":"10.1016\/j.intimp.2023.109955_b0195","doi-asserted-by":"crossref","first-page":"13689","DOI":"10.1128\/JVI.01595-12","article-title":"Myeloid-derived suppressor cells regulate natural killer cell response to adenovirus-mediated gene transfer","volume":"86","author":"Zhu","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2023.109955_b0200","first-page":"1260","article-title":"Transitory presence of myeloid-derived suppressor cells in neonates is critical for control of inflammation","volume":"49","author":"He","year":"2019","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2023.109955_b0205","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.lungcan.2013.06.005","article-title":"Arginase-1 mRNA expression correlates with myeloid-derived suppressor cell levels in peripheral blood of NSCLC patients","volume":"81","author":"Heuvers","year":"2013","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.intimp.2023.109955_b0210","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1182\/blood-2006-06-031856","article-title":"L-arginine availability regulates T-lymphocyte cell-cycle progression","volume":"109","author":"Rodriguez","year":"2007","journal-title":"Blood."},{"issue":"2","key":"10.1016\/j.intimp.2023.109955_b0215","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1158\/0008-5472.CAN-05-1299","article-title":"Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host","volume":"66","author":"Huang","year":"2006","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.intimp.2023.109955_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108571","article-title":"Distinct Populations of Immune-Suppressive Macrophages Differentiate from Monocytic Myeloid-Derived Suppressor Cells in Cancer","volume":"33","author":"Kwak","year":"2020","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.intimp.2023.109955_b0225","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1189\/jlb.3A0414-210R","article-title":"Cross-talk among myeloid-derived suppressor cells, macrophages, and tumor cells impacts the inflammatory milieu of solid tumors","volume":"96","author":"Beury","year":"2014","journal-title":"J. Leukocyte Biol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109955_b0230","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4049\/jimmunol.182.1.240","article-title":"Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1","volume":"182","author":"Li","year":"2009","journal-title":"J. Immunol. (Baltimore, Md : 1950)"},{"issue":"3","key":"10.1016\/j.intimp.2023.109955_b0235","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/hep.23054","article-title":"Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor","volume":"50","author":"Hoechst","year":"2009","journal-title":"Hepatology (Baltimore, Md)."},{"issue":"1","key":"10.1016\/j.intimp.2023.109955_b0240","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/eji.201948240","article-title":"Human monocytic myeloid-derived suppressor cells impair B-cell phenotype and function in vitro","volume":"50","author":"Jaufmann","year":"2020","journal-title":"Eur J Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2023.109955_b0245","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ni.2001","article-title":"The immune system in atherosclerosis","volume":"12","author":"Hansson","year":"2011","journal-title":"Nat. Immunol."},{"issue":"20","key":"10.1016\/j.intimp.2023.109955_b0250","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1007\/s00018-013-1289-1","article-title":"Inflammation and immune system interactions in atherosclerosis","volume":"70","author":"Legein","year":"2013","journal-title":"Cell. Mol. Life Sci. : CMLS."},{"issue":"2","key":"10.1016\/j.intimp.2023.109955_b0255","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.atherosclerosis.2012.03.016","article-title":"Regulatory T cells and IL-10 levels are reduced in patients with vulnerable coronary plaques","volume":"222","author":"George","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.intimp.2023.109955_b0260","first-page":"10","article-title":"Macrophage Polarization: Different Gene Signatures in M1(LPS+) vs. Classically and M2(LPS-) vs. Alternatively Activated Macrophages","author":"Orecchioni","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2023.109955_b0265","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/eurheartj\/ehy714","article-title":"Deficiency of the T cell regulator Casitas B-cell lymphoma-B aggravates atherosclerosis by inducing CD8(+) T cell-mediated macrophage death","volume":"40","author":"Seijkens","year":"2019","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.intimp.2023.109955_b0270","doi-asserted-by":"crossref","DOI":"10.3390\/biom8030080","article-title":"Research Progress on the Relationship between Atherosclerosis and Inflammation","volume":"8","author":"Zhu","year":"2018","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.intimp.2023.109955_b0275","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/cvr\/cvw114","article-title":"CD11b(+)Gr-1(+) myeloid-derived suppressor cells reduce atherosclerotic lesion development in LDLr deficient mice","volume":"111","author":"Foks","year":"2016","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.intimp.2023.109955_b0280","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-021-03207-4","article-title":"Bilirubin ameliorates murine atherosclerosis through inhibiting cholesterol synthesis and reshaping the immune system","volume":"20","author":"Wen","year":"2022","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.intimp.2023.109955_b0285","first-page":"1370","article-title":"The inhibitor of autophagy SBI-0206965 aggravates atherosclerosis through decreasing myeloid-derived suppressor cells","volume":"19","author":"Wang","year":"2020","journal-title":"Exp. Ther. Med."},{"issue":"6801","key":"10.1016\/j.intimp.2023.109955_b0290","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35025203","article-title":"Atherosclerosis","volume":"407","author":"Lusis","year":"2000","journal-title":"Nature."},{"issue":"2","key":"10.1016\/j.intimp.2023.109955_b0295","first-page":"62","article-title":"A brief overview of currently used atherosclerosis treatment approaches targeting lipid metabolism alterations","volume":"10","author":"Poznyak","year":"2020","journal-title":"Am. J. Cardiovasc. Dis."},{"key":"10.1016\/j.intimp.2023.109955_b0300","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.freeradbiomed.2019.03.036","article-title":"An update on lipid oxidation and inflammation in cardiovascular diseases","volume":"144","author":"Zhong","year":"2019","journal-title":"Free Rad. Biol. Med."},{"issue":"10","key":"10.1016\/j.intimp.2023.109955_b0305","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1344804","article-title":"Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells","volume":"6","author":"Al-Khami","year":"2017","journal-title":"Oncoimmunology."},{"key":"10.1016\/j.intimp.2023.109955_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2021.104286","article-title":"Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy","volume":"362","author":"Adeshakin","year":"2021","journal-title":"Cell. Immunol."},{"unstructured":"H. Basit, A. Malik, M.R. Huecker, Non ST Segment Elevation Myocardial Infarction. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2022, StatPearls Publishing LLC, 2022.","key":"10.1016\/j.intimp.2023.109955_b0315"},{"key":"10.1016\/j.intimp.2023.109955_b0320","doi-asserted-by":"crossref","DOI":"10.3390\/cells10040865","article-title":"Atherothrombosis in Acute Coronary Syndromes-From Mechanistic Insights to Targeted Therapies","volume":"10","author":"Khandkar","year":"2021","journal-title":"Cells."},{"key":"10.1016\/j.intimp.2023.109955_b0325","doi-asserted-by":"crossref","first-page":"4904217","DOI":"10.1155\/2020\/4904217","article-title":"Immune and Inflammation in Acute Coronary Syndrome: Molecular Mechanisms and Therapeutic Implications","volume":"2020","author":"Wang","year":"2020","journal-title":"J. Immunol. Res."},{"issue":"1","key":"10.1016\/j.intimp.2023.109955_b0330","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1161\/CIRCRESAHA.118.311098","article-title":"Reassessing the Mechanisms of Acute Coronary Syndromes The \u201cVulnerable Plaque\u201d and Superficial Erosion","volume":"124","author":"Libby","year":"2019","journal-title":"Circ. Res."},{"issue":"8 Suppl","key":"10.1016\/j.intimp.2023.109955_b0335","doi-asserted-by":"crossref","first-page":"C13","DOI":"10.1016\/j.jacc.2005.10.065","article-title":"Pathology of the vulnerable plaque","volume":"47","author":"Virmani","year":"2006","journal-title":"J. Am. College Cardiol."},{"key":"10.1016\/j.intimp.2023.109955_b0340","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/659282","article-title":"Role of matrix metalloproteinase-8 in atherosclerosis","volume":"2013","author":"Lenglet","year":"2013","journal-title":"Mediators Inflamm."},{"issue":"3","key":"10.1016\/j.intimp.2023.109955_b0345","first-page":"3238","article-title":"Role of CD11b+Gr-1+ myeloid cells in AGEs-induced myocardial injury in a mice model of acute myocardial infarction","volume":"8","author":"Yao","year":"2015","journal-title":"Int J Clin Exp Pathol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109955_b0350","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1080\/07853890.2022.2084153","article-title":"Blocking the A(2B) adenosine receptor alleviates myocardial damage by inhibiting spleen-derived MDSC mobilisation after acute myocardial infarction","volume":"54","author":"Yu","year":"2022","journal-title":"Ann. Med."},{"issue":"1","key":"10.1016\/j.intimp.2023.109955_b0355","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000369696","article-title":"Expansion of myeloid-derived suppressor cells in patients with acute coronary syndrome","volume":"35","author":"Wang","year":"2015","journal-title":"Cell. Physiol. Biochem.: Int. J. Experim. Cell. Physiol., Biochem., Pharmacol."},{"key":"10.1016\/j.intimp.2023.109955_b0360","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1038\/srep04774","article-title":"Hydrogen sulfide attenuates the recruitment of CD11b(+)Gr-1(+) myeloid cells and regulates Bax\/Bcl-2 signaling in myocardial ischemia injury","volume":"4","author":"Zhang","year":"2014","journal-title":"Sci Rep."},{"issue":"4","key":"10.1016\/j.intimp.2023.109955_b0365","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.bbrc.2017.10.009","article-title":"MMP-9-cleaved osteopontin isoform mediates tumor immune escape by inducing expansion of myeloid-derived suppressor cells","volume":"493","author":"Shao","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2023.109955_b0370","doi-asserted-by":"crossref","first-page":"18014","DOI":"10.1038\/nrdp.2018.14","volume":"4","author":"Oparil","year":"2018","journal-title":"Hypertens. Nat. Rev. Dis. Prim."},{"issue":"3","key":"10.1016\/j.intimp.2023.109955_b0375","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1152\/physrev.00031.2016","article-title":"Role of the Immune System in Hypertension","volume":"97","author":"Rodriguez-Iturbe","year":"2017","journal-title":"Physiol Rev."},{"issue":"3","key":"10.1016\/j.intimp.2023.109955_b0380","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1681\/ASN.2015050562","article-title":"Immune Mechanisms in Arterial Hypertension","volume":"27","author":"Wenzel","year":"2016","journal-title":"J. Am. Soc Nephrol.: JASN."},{"key":"10.1016\/j.intimp.2023.109955_b0385","doi-asserted-by":"crossref","first-page":"14037","DOI":"10.1038\/ncomms14037","article-title":"CD8(+) T cells stimulate Na-Cl co-transporter NCC in distal convoluted tubules leading to salt-sensitive hypertension","volume":"8","author":"Liu","year":"2017","journal-title":"Nat Commun."},{"issue":"3","key":"10.1016\/j.intimp.2023.109955_b0390","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1161\/HYPERTENSIONAHA.118.11828","article-title":"B-Cell Deficiency Lowers Blood Pressure in Mice","volume":"73","author":"Dingwell","year":"2019","journal-title":"Hypertension."},{"issue":"10","key":"10.1016\/j.intimp.2023.109955_b0395","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1161\/CIRCRESAHA.115.306539","article-title":"Myeloid Suppressor Cells Accumulate and Regulate Blood Pressure in Hypertension","volume":"117","author":"Shah","year":"2015","journal-title":"Circ Res."},{"issue":"1","key":"10.1016\/j.intimp.2023.109955_b0400","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1161\/HYPERTENSIONAHA.117.10306","article-title":"Myeloid-Derived Suppressor Cells Ameliorate Cyclosporine A-Induced Hypertension in Mice","volume":"71","author":"Chiasson","year":"2018","journal-title":"Hypertension."},{"issue":"3","key":"10.1016\/j.intimp.2023.109955_b0405","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1161\/HYPERTENSIONAHA.119.12761","article-title":"High Salt Activates CD11c(+) Antigen-Presenting Cells via SGK (Serum Glucocorticoid Kinase) 1 to Promote Renal Inflammation and Salt-Sensitive Hypertension","volume":"74","author":"Van Beusecum","year":"2019","journal-title":"Hypertension."},{"key":"10.1016\/j.intimp.2023.109955_b0410","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/978-3-319-57613-8_10","article-title":"Cardiac Autoimmunity: Myocarditis","volume":"1003","author":"Bracamonte-Baran","year":"2017","journal-title":"Adv. Experim. Med. Biol."},{"issue":"33","key":"10.1016\/j.intimp.2023.109955_b0415","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Caforio","year":"2013","journal-title":"Eur Heart J."},{"issue":"3","key":"10.1016\/j.intimp.2023.109955_b0420","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.ajpath.2014.11.023","article-title":"Natural Killer Cells Limit Cardiac Inflammation and Fibrosis by Halting Eosinophil Infiltration","volume":"185","author":"Ong","year":"2015","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.intimp.2023.109955_b0425","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/01.RES.85.6.551","article-title":"Susceptibility to myocarditis is dependent on the response of alphabeta T lymphocytes to coxsackieviral infection","volume":"85","author":"Opavsky","year":"1999","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.intimp.2023.109955_b0430","doi-asserted-by":"crossref","first-page":"6066","DOI":"10.1096\/fj.201701408R","article-title":"Immunomodulation by adoptive regulatory T-cell transfer improves Coxsackievirus B3-induced myocarditis","volume":"32","author":"Pappritz","year":"2018","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.intimp.2023.109955_b0435","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0167-5273(96)02588-0","article-title":"The role of sensitized T-cells in myocarditis and dilated cardiomyopathy","volume":"54","author":"Schwimmbeck","year":"1996","journal-title":"Int. J. Cardiol."},{"issue":"5","key":"10.1016\/j.intimp.2023.109955_b0440","doi-asserted-by":"crossref","DOI":"10.3390\/v13050889","article-title":"Myeloid-Derived Suppressor Cells Restrain Natural Killer Cell Activity in Acute Coxsackievirus B3-Induced Myocarditis","volume":"13","author":"M\u00fcller","year":"2021","journal-title":"Viruses."},{"issue":"3","key":"10.1016\/j.intimp.2023.109955_b0445","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.3390\/ijms15033356","article-title":"Galectin-9 induced myeloid suppressor cells expand regulatory T cells in an IL-10-dependent manner in CVB3-induced acute myocarditis","volume":"15","author":"Zhang","year":"2014","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.intimp.2023.109955_b0450","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.molimm.2017.01.013","article-title":"Expansion of CD11b(+)Ly-6C(+) myeloid-derived suppressor cells (MDSCs) driven by galectin-9 attenuates CVB3-induced myocarditis","volume":"83","author":"Zhang","year":"2017","journal-title":"Mol. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2023.109955_b0455","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.4049\/jimmunol.1002928","article-title":"Myeloid-derived suppressor cells infiltrate the heart in acute Trypanosoma cruzi infection","volume":"187","author":"Cuervo","year":"2011","journal-title":"Journal of immunology (Baltimore, Md : 1950)"},{"key":"10.1016\/j.intimp.2023.109955_b0460","doi-asserted-by":"crossref","first-page":"22658","DOI":"10.1038\/srep22658","article-title":"Monocytic myeloid-derived suppressor cells from females, but not males, alleviate CVB3-induced myocarditis by increasing regulatory and CD4(+)IL-10(+) T cells","volume":"6","author":"Su","year":"2016","journal-title":"Sci Rep."},{"issue":"1","key":"10.1016\/j.intimp.2023.109955_b0465","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ejhf.2333","volume":"24","author":"McDonagh","year":"2022","journal-title":"European journal of heart failure."},{"issue":"11","key":"10.1016\/j.intimp.2023.109955_b0470","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/ejhf.942","article-title":"Immune mechanisms in heart failure","volume":"19","author":"Zhang","year":"2017","journal-title":"European journal of heart failure."},{"issue":"7","key":"10.1016\/j.intimp.2023.109955_b0475","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20071698","article-title":"Cross-Talk between Neurohormonal Pathways and the Immune System in Heart Failure: A Review of the Literature","volume":"20","author":"De Angelis","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"21","key":"10.1016\/j.intimp.2023.109955_b0480","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1161\/CIRCULATIONAHA.113.007101","article-title":"CD4(+) T Cells Promote the Transition From Hypertrophy to Heart Failure During Chronic Pressure Overload","volume":"129","author":"Laroumanie","year":"2014","journal-title":"Circulation."},{"key":"10.1016\/j.intimp.2023.109955_b0485","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.116.309001","article-title":"Proliferation and Recruitment Contribute to Myocardial Macrophage Expansion in Chronic Heart Failure","volume":"119","author":"Sager","year":"2016","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.intimp.2023.109955_b0490","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1161\/ATVBAHA.112.251579","article-title":"Low levels of circulating CD4+FoxP3+ T cells are associated with an increased risk for development of myocardial infarction but not for stroke","volume":"32","author":"Wigren","year":"2012","journal-title":"Arteriosc., Thromb., Vasc. Biol."},{"key":"10.1016\/j.intimp.2023.109955_b0495","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.yjmcc.2013.04.023","article-title":"Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction","volume":"62","author":"Yan","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109955_b0500","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/CIRCULATIONAHA.117.030811","article-title":"Cardioprotective Role of Myeloid-Derived Suppressor Cells in Heart Failure","volume":"138","author":"Zhou","year":"2018","journal-title":"Circulation."},{"issue":"3","key":"10.1016\/j.intimp.2023.109955_b0505","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.008550","article-title":"Exercise Training Protects Against Heart Failure Via Expansion of Myeloid-Derived Suppressor Cells Through Regulating IL-10\/STAT3\/S100A9 Pathway","volume":"15","author":"Feng","year":"2022","journal-title":"Circulat. Heart Failure."},{"unstructured":"H. Mahmaljy, V.S. Yelamanchili, M. Singhal, Dilated Cardiomyopathy. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2022, StatPearls Publishing LLC, 2022.","key":"10.1016\/j.intimp.2023.109955_b0510"},{"issue":"6","key":"10.1016\/j.intimp.2023.109955_b0515","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1159\/000445595","article-title":"Activated Circulating Myeloid-Derived Suppressor Cells in Patients with Dilated Cardiomyopathy","volume":"38","author":"Zhang","year":"2016","journal-title":"Cell. Physiol. Biochem.: Int. J. Experim. Cell. Physiol., Biochem., Pharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2023.109955_b0520","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","article-title":"Cardiac fibrosis","volume":"117","author":"Frangogiannis","year":"2021","journal-title":"Cardiovasc Res."},{"issue":"6","key":"10.1016\/j.intimp.2023.109955_b0525","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41419-021-03874-7","article-title":"G-MDSCs promote aging-related cardiac fibrosis by activating myofibroblasts and preventing senescence","volume":"12","author":"Sun","year":"2021","journal-title":"Cell Death Dis."},{"year":"2022","author":"Ludhwani","series-title":"Heart Transplantation Rejection StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2022","key":"10.1016\/j.intimp.2023.109955_b0530"},{"issue":"4","key":"10.1016\/j.intimp.2023.109955_b0535","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.transproceed.2015.10.060","article-title":"Myeloid-derived Suppressor Cells Recruit CD4(+)\/Foxp3(+) Regulatory T Cells in a Murine Cardiac Allograft","volume":"48","author":"Nakamura","year":"2016","journal-title":"Transplant Proc."},{"issue":"13","key":"10.1016\/j.intimp.2023.109955_b0540","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.ejca.2008.06.031","article-title":"VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis","volume":"44","author":"Hawinkels","year":"2008","journal-title":"Eur J Cancer."},{"issue":"4","key":"10.1016\/j.intimp.2023.109955_b0545","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ccr.2004.08.031","article-title":"Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis","volume":"6","author":"Yang","year":"2004","journal-title":"Cancer Cell"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923002758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923002758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:50:12Z","timestamp":1761587412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923002758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":109,"alternative-id":["S1567576923002758"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109955","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of myeloid-derived immunosuppressive cells in cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109955","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109955"}}